Clinical Trial Update: Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating citrate as an anticoagulant alternative to heparin for babies on extracorporeal membrane oxygenation (ECMO); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Defects
• Respiratory Insufficiency

Drugs mentioned

• Heparin (unfractionated heparin)
• Trisodium citrate (trisodium citrate)

Snippet

Sponsor: Vanderbilt University | Conditions: Heart Defects, Congenital, Respiratory Insufficiency | EARLY_Phase 1 | Status: COMPLETED